Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

Medically reviewed by Stella Bard, MD Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common types of ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

“Asthma and rheumatoid arthritis (RA) are both prevalent diseases ... oral corticosteroids, biologics and azathioprine. Ramonell and Wenzel called these findings that eight of nine patients ...

A link between rheumatoid arthritis and appendicitis has been investigated before, but newer research has not confirmed these findings. Rheumatoid arthritis is an autoimmune disease where the ...

The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...

Rheumatoid Arthritis Awareness Day 2025 is observed on February 2. Created in 2013 by the Rheumatoid Patient Foundation, it is to raise awareness around the chronic autoimmune disease. Rheumatoid ...

Study links systemic inflammation, marked by high CRP and ESR, to interstitial lung disease risk in rheumatoid arthritis, highlighting the need for close monitoring.